DRKS00017084招募中未知

A multicentre PROspective study on the diagnostic value of Steroid profiling in primary ALDOsteronism: The PROSALDO study - PROSALDO

Medizinische Klinik und Poliklinik IV, Klinikum der Universität, LMU München0 个研究点目标入组 1,500 人开始时间: 2020年1月17日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Male and female adult patients (18-70 yr) with hypertension who are suspected to have PA and in whom other causes of secondary hypertension have been excluded according to standard clinical criteria
•All subjects must have read, understood and signed the informed consent form before inclusion into the study protocol

•Patients with other forms of secondary hypertension
•Subjects who need medications that may interfere with or invalidate outcome parameters (e.g., steroids, oral contraceptives)
•Patients with low or low-normal aldosterone (basal aldosterone <6.1 ng/dl) (<170 pmol/l)
•Pregnancy
•Patients with impaired mental capacity that precludes informed consent
•Patients at risk of allergic reaction to contrast media
•Unsuitability for or objection to undergo AVS, CT or adrenal surgery
•Severe or terminal co-morbidity which seriously interferes with possible treatment or health related quality of life

发起方

Medizinische Klinik und Poliklinik IV, Klinikum der Universität, LMU München